Biologicals

Yellow Fever

Requirements for yellow fever vaccine, Annex 2

(Requirements for Biological Substances, No. 3, revised 1995) WHO Technical Report Series, No. 872, 1998

Proposed amendments to the Requirements for Yellow Fever Vaccines (Requirements for Biological Substances No. 3, Annex 2) WHO Technical Report Series No. 872

UPCOMING EVENTS


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971